Aggregation‐induced emission luminogens for in vivo molecular imaging and theranostics in cancer
Abstract Cancer is one of the most fatal diseases for decades. Aggregation‐induced emission luminogens (AIEgens) have been recently used as molecular imaging or therapeutic agents in cancers, due to the advantages of large Stokes shift, high quantum yield, great biocompatibility, and strong photosta...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-10-01
|
Series: | Aggregate |
Subjects: | |
Online Access: | https://doi.org/10.1002/agt2.352 |
_version_ | 1827787530382082048 |
---|---|
author | Peili Cen Jiani Huang Chentao Jin Jing Wang Yen Wei Hong Zhang Mei Tian |
author_facet | Peili Cen Jiani Huang Chentao Jin Jing Wang Yen Wei Hong Zhang Mei Tian |
author_sort | Peili Cen |
collection | DOAJ |
description | Abstract Cancer is one of the most fatal diseases for decades. Aggregation‐induced emission luminogens (AIEgens) have been recently used as molecular imaging or therapeutic agents in cancers, due to the advantages of large Stokes shift, high quantum yield, great biocompatibility, and strong photostability. AIEgens can specifically target different types of cancer via diverse targeting strategies. AIEgen‐based fluorescence imaging, especially near‐infrared imaging, demonstrated deep penetration and suitable signal‐to‐noise ratio, which allows reliable in vivo cancer imaging. Combined with other imaging modalities, AIEgen‐based multimodal imaging could provide multidimensional cancer hallmarks from different perspectives. In addition, AIEgen‐based phototherapy can be used for photodynamic therapy and photothermal therapy, which facilitate ablation of cancer cells with good biosafety and high therapeutic effects in vivo. AIEgens nanoparticles fabricated with some specific chemicals, drugs, or siRNA, could display synergistic therapeutic effects for cancers. This paper comprehensively describes the current status and future perspectives of AIEgens, which have showed a great potential for the future preclinical and clinical translation on in vivo molecular imaging and theranostics in cancer. |
first_indexed | 2024-03-11T16:51:11Z |
format | Article |
id | doaj.art-39460f67a61c4ea5989f2e3c50965a61 |
institution | Directory Open Access Journal |
issn | 2692-4560 |
language | English |
last_indexed | 2024-03-11T16:51:11Z |
publishDate | 2023-10-01 |
publisher | Wiley |
record_format | Article |
series | Aggregate |
spelling | doaj.art-39460f67a61c4ea5989f2e3c50965a612023-10-21T07:53:27ZengWileyAggregate2692-45602023-10-0145n/an/a10.1002/agt2.352Aggregation‐induced emission luminogens for in vivo molecular imaging and theranostics in cancerPeili Cen0Jiani Huang1Chentao Jin2Jing Wang3Yen Wei4Hong Zhang5Mei Tian6Department of Nuclear Medicine and PET Center The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou Zhejiang ChinaDepartment of Nuclear Medicine and PET Center The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou Zhejiang ChinaDepartment of Nuclear Medicine and PET Center The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou Zhejiang ChinaDepartment of Nuclear Medicine and PET Center The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou Zhejiang ChinaDepartment of Chemistry and the Tsinghua Center for Frontier Polymer Research Tsinghua University Beijing ChinaDepartment of Nuclear Medicine and PET Center The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou Zhejiang ChinaDepartment of Nuclear Medicine and PET Center The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou Zhejiang ChinaAbstract Cancer is one of the most fatal diseases for decades. Aggregation‐induced emission luminogens (AIEgens) have been recently used as molecular imaging or therapeutic agents in cancers, due to the advantages of large Stokes shift, high quantum yield, great biocompatibility, and strong photostability. AIEgens can specifically target different types of cancer via diverse targeting strategies. AIEgen‐based fluorescence imaging, especially near‐infrared imaging, demonstrated deep penetration and suitable signal‐to‐noise ratio, which allows reliable in vivo cancer imaging. Combined with other imaging modalities, AIEgen‐based multimodal imaging could provide multidimensional cancer hallmarks from different perspectives. In addition, AIEgen‐based phototherapy can be used for photodynamic therapy and photothermal therapy, which facilitate ablation of cancer cells with good biosafety and high therapeutic effects in vivo. AIEgens nanoparticles fabricated with some specific chemicals, drugs, or siRNA, could display synergistic therapeutic effects for cancers. This paper comprehensively describes the current status and future perspectives of AIEgens, which have showed a great potential for the future preclinical and clinical translation on in vivo molecular imaging and theranostics in cancer.https://doi.org/10.1002/agt2.352aggregation‐induced emissioncancernear‐infrared imagingphototherapytargeting strategytheranostics |
spellingShingle | Peili Cen Jiani Huang Chentao Jin Jing Wang Yen Wei Hong Zhang Mei Tian Aggregation‐induced emission luminogens for in vivo molecular imaging and theranostics in cancer Aggregate aggregation‐induced emission cancer near‐infrared imaging phototherapy targeting strategy theranostics |
title | Aggregation‐induced emission luminogens for in vivo molecular imaging and theranostics in cancer |
title_full | Aggregation‐induced emission luminogens for in vivo molecular imaging and theranostics in cancer |
title_fullStr | Aggregation‐induced emission luminogens for in vivo molecular imaging and theranostics in cancer |
title_full_unstemmed | Aggregation‐induced emission luminogens for in vivo molecular imaging and theranostics in cancer |
title_short | Aggregation‐induced emission luminogens for in vivo molecular imaging and theranostics in cancer |
title_sort | aggregation induced emission luminogens for in vivo molecular imaging and theranostics in cancer |
topic | aggregation‐induced emission cancer near‐infrared imaging phototherapy targeting strategy theranostics |
url | https://doi.org/10.1002/agt2.352 |
work_keys_str_mv | AT peilicen aggregationinducedemissionluminogensforinvivomolecularimagingandtheranosticsincancer AT jianihuang aggregationinducedemissionluminogensforinvivomolecularimagingandtheranosticsincancer AT chentaojin aggregationinducedemissionluminogensforinvivomolecularimagingandtheranosticsincancer AT jingwang aggregationinducedemissionluminogensforinvivomolecularimagingandtheranosticsincancer AT yenwei aggregationinducedemissionluminogensforinvivomolecularimagingandtheranosticsincancer AT hongzhang aggregationinducedemissionluminogensforinvivomolecularimagingandtheranosticsincancer AT meitian aggregationinducedemissionluminogensforinvivomolecularimagingandtheranosticsincancer |